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Clostridium perfringens is a fulminant infection that aﬀects patients with a high rate of morbidity and mortality. Fortunately,
C. perfringens-associated sepsis and death in the gynecologic patient is rarely encountered. We report a case of intrauterine C.
perfringens presenting as life-threatening sepsis in a postmenopausal patient.
1.Introduction
Before abortion was legalized in the United States in 1973,
reports of Clostridium perfringens (formally known as
Clostridium welchii) commonly occurred in gynecologic
patients and resulted in devastating consequences [1].
Although the incidence has markedly decreased, mortality
rates continue to remain high with deaths reported in 10%
to 85% of patients presenting with C. perfringens sepsis
[1–3].
2.CaseReport
A 60-year-old female presented to emergency services (ER)
reporting a 6-hour history of myalgia, suprapubic pain, and
febrile morbidity (38.9
◦C/102
◦F). The patient was consid-
ered to be of her normal state of health prior to the onset
of symptoms. Her gynecologic history was noncontributory
and her medical comorbidities consisted of stable hyperten-
sion and chronic obstructive pulmonary disease. Initial sig-
niﬁcant physical examination ﬁndings and laboratory results
were as follows: lower abdominal pain without rebound
or guarding and leukocytosis (WBC 22,000/mm3 and 39%
bands). The patient was initially admitted with sepsis (not
otherwise speciﬁed) to the general medicine service and was
prescribed intravenous antimicrobial therapy (ampicillin
sodium/sulbactam sodium). Within 6 hours after admission,
the patient complained of increasing abdominopelvic pain
and developed clinical signs of sepstic shock. Intravenous
gentamycinandclindamycinwereaddedtotheantimicrobial
regimen, and the patient was transferred to the medical
intensive care unit (MICU). Computed tomography (CT)
revealed normal abdominal anatomy except for a uterus
measuring 21cm × 16cm with ﬂuid within the endometrial
cavity and multiple leiomyomas (no evidence of myometrial
gas). Gynecology was consulted and further examination
conﬁrmed a pelvic mass with suprapubic and cervical
motion tenderness. After bedside endometrial biopsy was
unable to be performed secondary to cervical stenosis, an
ultrasound-guided transvaginal endometrial biopsy was per-
formed as previously described [4]. The patient’s condition
continued to worsen and clinical management was compli-
cated by the development of anemia, hyperbilirubinemia,
hemoglobinemia, hemoglobinuria, and hypotension requir-
ing blood transfusion and vasoactive support. Gram stain of
the intrauterine ﬂuid revealed gram-positive rods. Because
of evidence suggestive of an intrauterine clostridial infection,
an emergent total abdominal hysterectomy and bilateral
salpingooophorectomy was performed without operative
complications. Intraoperative ﬁndings revealed an enlarged
ﬁbroid uterus with inﬂammatory changes involving the uter-
ine serosa, no evidence of tubo-ovarian abscess or infection2 Case Reports in Medicine
Table 1: Summary of cases of Clostridium perfringens in middle-aged (age > 45 years) women.
Reference Age Uterine pathology Clinical conditionsa X-Rayb Surgery Death
Kaufmannet al. [5] 56 Leiomyoma
Fever
Yes
c No
d Yes
Hemolysis/anemia
Hyperbilirubinemia
Hemoglobinemia
Hemoglobinuria
Hypotension
Symondsand Robertson [6] 57 Endometrial adenocarcinoma
Fever
No No Yes
Hemolysis/anemia
Hyperbilirubinemia
Hemoglobinemia
Hemoglobinuria
49 Endometrial adenocarcinoma Fever No No No
Hyperbilirubinemia
Bravermanet al. [7] 64 Endometrial adenocarcinoma
Fever
Yes Yes No Anemia
c
Hyperbilirubinemia
Bryant 60 Leiomyoma
Fever
Yes Yes No
Hemolysis/anemia
Hyperbilirubinemia
Hemoglobinemia
Hemoglobinuria
Hypotension
aClinical conditions are a summary of the laboratory and physical exam ﬁndings reported in the manuscript
bX-ray includes plain ﬁlm, sonogram, or computed tomography
cX-ray was performed postmortem
dUterus was examined during autopsy.
involving the extrauterine structures. Postoperatively, the
patient recovered fully after 4 days of MICU support and 13
days of hospitalization. Final pathology of the surgical spec-
imen revealed a degenerating leiomyoma with intramural
myonecrosis without evidence of malignancy. Final culture
of blood and intrauterine specimens revealed Clostridium
perfringens.
3. Discussion
After conducting a MEDLINE inquiry of English-language
citations for the years 1970 through 2009, using the search
phrases“clostridiumandpostmenopausal,”“clostridiumand
uterine,” “clostridium and leiomyoma,” and “clostridium
and gynecologic cancer,” we identiﬁed 5 cases (Table 1)o f
middle-aged women (Age > 45 years) treated for uterine
Clostridium perfringens- (previously known as C. welchii)
associated sepsis. This is the second case, in 35 years,
of C. perfringens sepsis complicating a degenerating uter-
ine leiomyoma.
Clostridium perfringens is an anaerobic, gram-positive
rod-shaped organism, that, through the production of
extracellular toxins (mainly alpha), produces characteristic
local and systemic eﬀects resulting in myonecrosis, shock,
and potential death [8]. C. perfringens has been isolated
from the vagina and cervix of 1% to 10% of healthy
women and is considered to be of no clinical signiﬁ-
cance in the absence of infection [2]. Only about 5%
of C. perfringens isolates actually cause a clinical illness
[9].
Clostridial infections complicating obstetrics and gyne-
cology patients are uncommon, but have been associated
with obstetrical and gynecologic conditions and/or treat-
ments [2, 5–7, 9–11]. C. perfringens infection appears to be
rare in middle-aged women (age > 45 years). Our report
is the 5th case described in the literature, and there have
been no reports of C. perfringens infection associated with
middle-aged women without instrumentation of the uterus
or coexisting uterine pathology.
As seen in our patient, the clinical presentation of C. per-
fringens is commonly associated with multisystem involve-
ment (hemolysis, hemoglobinuria, jaundice, uterine tender-
ness, and septic shock accompanied by renal failure) [2].
Althoughnotdemonstratedinourpatient,radiologicstudies
demonstrating gas patterns involving the myometrium are
highly suspicious for uterine C. perfringens infection. How-
ever, intrauterine gas pattern can be associated with other
conditions that may be treated with a more conservative
approach [2, 10].
Reductions in mortality appear to rely on promptness
in diagnosis, supportive care, broad spectrum antibiotics,
and surgical debridement. Timely, adequate antimicrobialCase Reports in Medicine 3
therapy is important for successful treatment of C. per-
fringens infections. Zaharet al. [3]r e p o r t e dad e c r e a s e
in the mortality from 63% to 14% with prompt ade-
quate antimicrobial therapy. Penicillin is considered the
drug of choice; however, in vitro susceptibility data has
demonstrated that combination antimicrobial therapy with
penicillin and clindamycin or tetracycline may further
reduce mortality through the reduction in toxin synthesis
[12, 13]. Hysterectomy without surgical resection of the
adnexal structures may be inadequate because of rapid C.
perfringens involvement of extrauterine structures [1]. If
prompt recognition and surgical treatment identify tubes
and ovaries without evidence of necrosis, the conservation
of the adnexal structures may not confer a poorer out-
come [14]. Conservative treatment with supportive care
and broad spectrum antibiotics (no surgical treatment)
is less commonly performed. A case series reported by
Lichtenbergand Henning [9] described no mortality among
womenwithclostridialinfectionandconservativetreatment.
However, the authors appropriately explained that none
of the patients in their series manifested any signs of
sepsis. Hyperbaric oxygen (HBO) has been used to treat
C. perfringens infections with varying eﬃcacy and the role
of HBO remains controversial [2, 15]. There is one report
of refractory C. perfringens infection that responded to
HBO after intravenous antibiotics and hysterectomy failed to
control the infection [11]. HBO may oﬀer an improvement
in outcome when used in combination with antimicrobial
therapy and surgery. However, HBO has not been studied in
a prospective manner and may be associated with signiﬁcant
complications [2].
Due to the limited number of reports of middle-aged
women treated for C. perfringens infection, it is diﬃcult to
identify clinical characteristics that may categorize patients
into surgical or nonsurgical treatment groups. Also because
of the proclivity for rapid deterioration with C. perfringens
infection, it may be clinically diﬃcult to allow for a
signiﬁcant length of treatment time to assess the eﬃcacy
of the antimicrobial therapy. In our review of the literature
(Table 1), 60% of middle-aged women with C. perfringens
infection died of their condition. Although clinical signs of
multisystem involvement were reported in all of the cases,
hemolysis was reported in 66% of patients with death as
an outcome. Only our patient demonstrated hemolysis and
survived treatment. This may be explained by the early
presentation of the patient, the use of broad-spectrum
antibiotics, and the early timing of antimicrobial and
surgical treatment [2]. Although some advocate dilatation
and curretage for patients without myometrial gas pattern
on imaging studies, the presence of hemolysis, as seen in
our patient, may be associated as a potential indicator for
poorer outcome and need for more aggressive treatment
[2].
In conclusion, C. perfringens is a rare condition aﬀect-
ing middle-aged women. This infection appears to be
more commonly associated with women with a history
of a uterine procedure or underlying pathology. Prompt
recognition and treatment are essential for an improved
survival.
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